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Background: Traditional subjective method for the analysis of time-intensity curves (TICs) from breast dynamic contrast
enhanced MRI (DCE-MRI) presented a low specificity. Hence, a semi-automatic quantitative method was proposed and
evaluated for distinguishing invasive ductal carcinomas from benign lesions.
Materials and methods: In the traditional method, the lesion was extracted by placing a region of interest (ROI)
manually. The mean curve of the TICs from the ROI was subjectively classified as one of three patterns. Only one
quantitative parameter, the mean value of maximum slope of increase (MSI), was provided. In the new method, the
lesion was identified semi-automatically, and the mean curve was classified quantitatively. Some additional parameters,
the signal intensity slope (SIslope), initial percentage of enhancement (Einitial), percentage of peak enhancement (Epeak),
early signal enhancement ratio (ESER), and second enhancement percentage (SEP) were derived from the mean curves
as well as the lesion areas. Wilcoxon’s test and receiver operating characteristic (ROC) analyses were performed,
and P < 0.05 was considered significant.
Results: According to the TIC classification results, the accuracies were 59.16% for the traditional manual
method and 76.05% for the new method (P < 0.05). For the mean MSI values from the manual method, the
accuracy was 63.35%. For the mean TICs derived from the semi-automatic method, the accuracies were 77.47%
for SIslope, 65.24% for MSI, 58.45% for Einitial, 66.20% for Epeak, 71.83% for ESER, and 54.93% for SEP, respectively.
For the lesion regions identified by the semi-automatic method, the accuracies were 73.24%, 72.54%, 58.45%,
62.68%, 64.09%, and 55.64%, respectively.
Conclusion: Compared with traditional subjective method, the semi-automatic quantitative method proposed in this study
showed a higher performance, and should be used as a supplementary tool to aid radiologist's subjective interpretation.
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Semi-automatic methodBackground
Breast cancer is one of the most common malignancies
in women worldwide and the second leading cause of
cancer death among women [1-3]. Although numerous
advances in prevention, surgical resection, and adjuvant
chemoradiotherapy have led to a decline in the overall
mortality due to breast cancer, the survival rates for* Correspondence: cmuguoqy@163.com
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unless otherwise stated.patients with metastatic disease have not significantly im-
proved. Consequently, the discovery of novel technique
involved in the diagnosis of breast cancer is of great value.
Due to its three-dimensional nature, MRI has been
considered as complementary to conventional mammog-
raphy for the evaluation of suspicious breast lesions [4].
It can detect cancers missed by mammography or ultra-
sound in women who have dense breasts. Thus, the
American Cancer Society has proposed that women with
a lifetime breast cancer risk of 20% or greater shoulds is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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[5,6]. Dynamic contrast enhanced MRI (DCE-MRI) is
one of the main imaging protocols that can provide a
series of high spatial resolution images over time. The
advantage of DCE-MRI over conventional imaging tech-
niques (such as mammography and ultrasonography) is
its ability to obtain and analyze both morphological and
functional features corresponding to lesion characteris-
tics [4,7]. For example, the time intensity curve (TIC) of
signal from DCE-MRI has been frequently used clinically
to characterize the biological and clinical aggressiveness
of breast lesions [7-9]. A key characteristic of the TIC
is the shape of the washout portion [10]. Generally,
DCE-MRI has been qualitatively analyzed using com-
mercially available software. First, a circular region of
interest (ROI) was placed by a breast radiologist onto
the parametric map reflecting the maximum slope of
increase (MSI) to include the suspicious lesion. The
mean TIC of signals within the ROI was calculated,
and then was subjectively classified as persistently en-
hancing (type I), where the signal intensity continued
to increase over time; plateau (type II), where the signal in-
tensity did not change over time after its initial increase
during the delayed phase; and washout (type III), where the
signal intensity decreased after reaching the highest point
of its initial increase during the delayed phase [10-16].
For conventional analysis of DCE-MRI based on the
manual method, there are several disadvantages. First,
the manual method is very time-consuming [17]. It is
very important to minimize reading time in large hospi-
tals like ours, which serve over 10,000 patients a day.
Second, due to a dependence on the operator, the results
from the manual method lack reproducibility for the
same observer at different time points and for different
observers at the same time point. Inter- and intra-
observer variabilities have been considered a substantial
limitation of the manual method [18-22]. Furthermore,
inconsistent breast DCE-MRI interpretations could re-
sult in adverse effects on disease diagnoses and evalua-
tions of treatments. Third, for the complete manual
method, accurate results were adversely affected by par-
tial volume effects when viable tumor tissue and necrosis
were closely located [22,23]. Sometimes, it is really diffi-
cult to assess the lesion's margins [6]. Fourth, recently
some studies have reported that although the conven-
tional method resulted in higher sensitivity in the deter-
mination of breast lesions, its specificity was low or
moderate [4,10,11,19,24-28]. Hence, in order to overcome
the weaknesses of the conventional method for DCE-MRI
analysis, it is necessary to develop a computer-aided
approach to increase the reading speed of breast DCE-
MRIs, to decrease the variability between inter- and
intra-observers, and to reduce the partial volume effect,
and to improve the diagnostic specificity.In the present study, we described a novel approach
for the analysis of signal TICs from breast DCE-MRIs.
In this novel method, the breast lesion area was better
identified using a semi-automatic segmentation algo-
rithm. Compared with traditional method drawing the
breast lesions manually, this algorithm might be able to
reduce the influence of partial volume effects on the
subsequent analysis. In addition, in order to avoid the
limitations involved in completely subjective determin-
ation of TIC patterns with naked eyes according to their
shape, the current method quantitatively classified the
TICs as one of three patterns. In our opinion, relative to
traditional subjective method, this can lead to more re-
producible results. To interpret DCE-MRI better, a var-
iety of computer-aided diagnosis (CAD) methods for the
analysis of enhancement kinetics were developed, among
which some focused on the measurement of hemodynamic
parameters based on Tofts and Kermode models, and
others concentrated on the analysis of TIC shape charac-
teristics. In this study, more enhancement information was
obtained by measuring a series of quantitative parameters,
including signal intensity slope, initial percentage of en-
hancement, percentage of peak enhancement, early signal
enhancement ratio, and second enhancement percentage.
The DCE-MRI data could therefore be utilized more
adequately. Because invasive ductal carcinoma (IDC) is
the most common type of breast carcinoma (accounting
for 70%-80%) [29,30], this type of malignant lesion was se-
lected as the research subject in the present study. The
prevalence of the investigated disease can make the study
more meaningful and facilitate the case collection.
To the best of our knowledge, this is the first study
comparing the traditional manual method and the novel
method which has been currently proposed for the dis-
crimination of breast IDCs and benign lesions. Overall,
this comparison should be useful in the improvement of
breast DCE-MRI diagnosis.Materials and methods
In this study, the performances of the conventional manual
method and the currently proposed semi-automatic method
were evaluated. The traditional method was performed
based on commercially available software embedded in the
dedicated workstation (FuncTool 9.4.05A, GE Healthcare,
Milwaukee, WI, USA). The newly proposed method was
performed using MATLAB software (version R2010b;
The MathWorks, Inc., USA) developed by ourselves.
The detailed process is described below.DCE-MRI acquisition and case collection
This study was approved by the ethics committee of
Shengjing Hospital. Because this is a retrospective study,
and all the cases used in this study were collected from
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each patient was waived.
All breast DCE-MRI images were acquired using a
3.0 tesla scanner (Signa HDxt; GE Healthcare, USA),
using a dedicated surface multichannel coil with the
patient in the prone position. After axial localization, dy-
namic examination was performed using the VIBRANT-VX
sequence with the following parameters: TR 7.42 ms, TE
4.25 ms, flip angle 15°, slice thickness 2.2 mm, spacing
between slice 2.2 mm, inversion time 20 ms, image
matrix 1024 × 1024, temporal acquisition 80 s, slice
number 78. The three-dimensional scanning sequence
was performed once before, and continuously eight
times after intravenous injection of the contrast agent
(0.5 mmol/ml, Gadodiamide, Omniscan,GE Healthcare;
Magnevist, Bayer-Shering Pharmaceuticals). The contrast-
enhanced study was performed with a bolus dose of
0.15 mmol per kilogram bodyweight, infused in the ante-
cubital vein by a power injector at a rate of 4 ml/s. After
that, an equal volume of saline flush succeeded at the
same flow speed.
The breast DCE-MRI images acquired between January
2009 and August 2014 were read retrospectively by a
breast-radiologist (13 years work experience in breast
MRI). Although some patients underwent multiple breast
DCE-MRI examinations before and after chemotherapeu-
tic or surgical treatment, in the present study, only the im-
ages used for diagnostic purposes before treatment were
collected for subsequent analyses. In order to facilitate the
segmentation of breast lesions, all the lesions were mass-
like and single (the lesions were either in the left or right
breast). In addition, each breast lesion was verified as
IDCs or benign lesions by biopsy or pathology after the
DCE-MRI examination (time interval between MRI and
histopathology examination was less than 5 days). As a
result, 142 cases (all female; age range, 22–79 years;
mean age, 53.5 years) were collected (71 benign cases
and 71 IDCs). The detailed diagnoses of these benign
lesions confirmed by pathology or biopsy are summa-
rized in Table 1.Table 1 Detailed histopathological diagnoses and
proportions of benign breast lesions
Lesion type n %
High risk (complex sclerosing lesion, FEA,
CCC with focal atypia)
5 7.04
Fibroadenoma, fibroadenomatous hyperplasia 33 46.48
Papilloma 4 5.63
DH, CCC, FCC, focal fibrosis, nodular
sclerosing adenosis
16 22.54
Miscellaneous (chronic abscess, gynecomastia,
fat necrosis, pseudoangiomatosis)
13 18.31
FEA = flat epithelial atypia, CCC = columnar cell changes, DH = ductal
hyperplasia, FCC = fibrocystic changes.Conventional method for TIC analysis
The selected images were transferred back to the work-
station from the PACS server for interpretation using
the dedicated software (FuncTool). Conventional meth-
odology for the analysis of TIC from DCE-MRI was per-
formed by an experienced breast-radiologist, who was
blinded to the patient’s clinical information. Image sub-
traction of basal acquisition from the post-contrast
dynamic images was performed to detect the suspicious
lesions (enhanced areas). As suggested by Cheung et al.,
the third post-contrast subtracted image was used for bet-
ter visualization of the lesion margin, and the slice with
the maximum sized lesion was selected for subsequent
analysis [13]. FuncTool produced a MSI map, and a circu-
lar ROI was manually placed onto the MSI map to cover
the suspicious lesion. Then the TICs from the ROI were
automatically averaged. Based upon the reader's subjective
judgment, the mean curve was categorized as "continued
signal intensity increase" (type I), "plateau" (type II), or
"washout" (type III), as shown in Figure 1 [4,29,31]. The
mean MSI value from the ROI was also automatically pro-
vided by the dedicated software.A novel method for TIC analysis
Semi-automatic segmentation of breast lesions
To eliminate the defects of manual extraction of breast
lesions, the proposed method determined the lesion area
semi-automatically. The segmentation procedure of breast
lesions involved the following steps.
First, a ROI of arbitrary shape was drawn around the
lesion;Figure 1 Different patterns of signal TICs. Type I is a progressive
enhancement feature involving a continuous increase in signal
intensity over time. Type II consists of a plateau pattern where there
is an initial contrast-molecule uptake, followed by a unalterable
phase. Type III shows a washout feature where there is an initial
rapid uptake followed by reduction in signal intensity.
Figure 2 Results of ROC analysis for the quantitative parameters. A-F showed the results for the mean curve, and G-L showed the results
for the target regions that were determined using the proposed method.
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Table 2 ROC analysis for the mean curve using the semi-automatic method
SIslope MSI Einital Epeak ESER SEP
AUC 0.813 0.595 0.578 0.676 0.765 0.501
SE 0.0443 0.0588 0.0583 0.0542 0.0475 0.0587
95% CI (0.722,0.884) (0.492,0.692) (0.475,0.676) (0.575,0.766) (0.669,0.844) (0.399,0.602)
Optimal cutoff ≤9.7039 >695.6076 >101.3672 ≤202.115 >74.3415 >197.7642
Sensitivity 83.10% 84.51% 91.55% 39.43% 81.69% 63.38%
Specificity 71.83% 45.07% 25.35% 92.96% 61.97% 46.48%
Accuracy 77.47% 65.24% 58.45% 66.20% 71.83% 54.93%
SE = standard error, CI = confidence interval.
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ROI [32], based on which pixels were divided into two
parts, i.e. background and foreground;
Third, morphological erosion was applied to the binary
image obtained above, and the size of structure element
was 4 × 4;
Fourth, the post-eroded image was traversed to obtain
the unique but largest eight-connected region;
Finally, morphological dilation was applied to the
unique region with a structure element of the same size.
The final region was considered as the target area corre-
sponding to the lesion.
Quantitative analysis of TIC
First, the TICs of signals in the target area were aver-
aged. In order to classify the mean TIC quantitatively,
the slope of signal intensity (SIslope) was measured using
the following equation:
SIslope ¼ SItail−SImeanð Þ=SImean½   100% ð1Þ
where SItail was the value of the curve at the last time
point, and SImean was the mean value of the first two
post-contrast time points (i.e., the value at the time
point of 120 S).The above mean curve was automatically
designated typeIwhen the SIslope value was +10% or
larger, type II when the SIslope value was between −10%
to +10%, and type III when the SIslope value was −10%
or lower [7,17,33]. Meanwhile, the SIslope correspondingTable 3 ROC analysis for the target region determined by the
SIslope MSI Einital
AUC 0.784 0.737 0.578
SE 0.0465 0.0503 0.0579
95% CI (0.691,0.860) (0.639,0.820) (0.475,
Optimal cutoff ≤15.0926 >1294.9921 >112.8
Sensitivity 83.10% 56.34% 88.73%
Specificity 63.38% 88.73% 28.17%
Accuracy 73.24% 72.54% 58.45%to the TIC of each pixel was also calculated automatically,
and the parametric map was obtained as well as the mean
SIslope value. Furthermore, the following additional quanti-
tative parameters not provided by the existing dedicated
software were also derived from the mean curve.
1) Maximum slope of increase:
MSI ¼ max SIiþ1−SIið Þ ð2Þ
where SIi and SIi + 1 denoted the signal intensities of the
former and the latter phases, respectively, with i ranging
from 0 to 7.
2) Initial percentage of enhancement (Einitial):
Einitial ¼ SI1−SI0½ =SI0  100 ð3Þ
where SI1 and SI0 represented the signal intensities of
the first post-contrast phase and the pre-contrast phase,
respectively [34].
3) Percentage of peak enhancement (Epeak):
Epeak ¼ SIpeak−SI0
 
=SI0  100 ð4Þ
where SIpeak represented the peak value of the contrast
enhancement [7,34].
4) Early signal enhancement ratio (ESER): [35]
ESER ¼ SI1−SI0ð Þ= SI2−SI0ð Þ  100 ð5Þ




0.676) (0.503,0.702) (0.578,0.769) (0.420,0.624)




Figure 3 ROC analysis for the mean MSI values derived from the
manual method, with values of 0.601 for AUC, 0.0584 for SE,
(0.498,0.698) for 95% CI, >884.4 for optimal cutoff value, 64.79%
for sensitivity, 61.91% for specificity, and 63.35% for accuracy.
Table 4 Comparison of the TIC classification results
obtained by the conventional and semi-automatic
method
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SEP ¼ SI2−SI0ð Þ=SI0  100 ð6Þ
In a similar manner, the above parameters for the tar-
get region were also calculated on a pixel-by-pixel basis,
and the color-coded map corresponding to each type of
quantitative parameter, as well as the mean value, were
automatically obtained.
Statistical analysis
For each type of quantitative parameter, receiver operating
characteristic (ROC) analysis was performed using the stat-
istical software MedCalc (version 14.10.20, http://www.
medcalc.org/). The area under the ROC curve (AUC), as
an index of diagnostic performance was provided automat-
ically as well as the optimal threshold, based on which spe-
cificity, sensitivity, and accuracy were obtained.
For the classification of mean TIC, cases with washout
or plateau curves (type II or III) were generally classified
as malignant, with the remaining cases classified as benign
[36,37]. Based on these assignments, the specificity, sensi-
tivity, and accuracy were again respectively obtained [38].
The paired-samples Wilcoxon test was performed using
SPSS software (version 16.0) for comparison between the
manual method and the proposed method. The difference
was considered significant with a P value less than 0.05.
Ethical standards and patient consent
Ethical clearance for this study was obtained from the
Ethics Committee at Shengjing Hospital, which is part of
China Medical University. Because this is a retrospective
study, and all the cases used in this study were collected
from the server of our PACS, written informed content
from each patient was waived.
Results
For the quantitative parameters, the results of ROC ana-
lysis are shown in Figure 2, Table 2, and Table 3, and the
results obtained using the conventional manual method
are shown in Figure 3. The results of TIC classification
are shown in Table 4. Statistical analysis showed that
there was a significant difference in the TIC classifica-
tion between the conventional subjective method and
the new quantitative method (Z = −4.324, P < 0.05).
A random case (45-years-old) was selected to illustrate
the results obtained with the manual method (Figure 4),
the procedure of lesion segmentation (Figure 5) and
quantitative parametric maps (Figure 6).
Discussion
As positron emission tomography, DCE-MRI can pro-
vide information about changes in vascularity, vascular
permeability, and the relative volume of the extracellularspace [28,29,39-41], but its cost is relatively low. It in-
volves a serial acquisition of T1-weighted images before
and after an intravenous injection of paramagnetic con-
trast agent (CA). As the CA enters into the tissue, the
MRI signal intensity will be changed depending on the
local distribution and concentration of CA. The MRI
signal intensity will then return to the baseline value
when the CA is transported out of the tissue. By analyz-
ing the associated signal intensity time course, parame-
ters related to physiological information can be obtained
for each image pixel and region of interest [35]. Conven-
tionally, the analysis of contrast-enhancement kinetics
was achieved by placing ROIs manually. This manual
method assumes accurate placement of the ROI in the
most appropriate lesion area.
The semi-automatic method for TIC analysis proposed
in the present study differs from the conventional manual
method in several aspects, which result in potential advan-
tages. First, the lesion determination was traditionally
based on the MSI map, while in the proposed method it
was based on the subtraction image between the post-
Figure 4 Results based on the manual method for the randomly selected case. A-C represent the MSI map, mask image (before injection of
the contrast agent), and the mean curve of TICs from the manually drawn ROI, respectively. The mean curve was qualitatively designated as type
II by the reader, and the mean MSI value was 1167.0. D is the pathological result showing breast adenosis (benign lesion).
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extraction was previously based on a manual operation,
but in the proposed study, it was completed using a
semi-automatic segmentation procedure. Third, in the
traditional method, TIC classification was subjectively
determined by a reader’s visual inspection, but in the
novel method, it was completely performed using a
quantitative method. Finally, the dedicated workstation
could only provide one quantitative parameter (MSI),
but in the proposed method, several additional quanti-
tative parameters related to the dynamic enhancement
information were also measured.
Relative to the conventional method for TIC analysis
of breast DCE-MRI, the new method proposed in the
present study showed better performance in several as-
pects. For TIC classification, the conventional method
resulted in relatively high sensitivity, but was also limited
by low specificity, as reported in almost all the previous
studies [4,10,11,19,24-28]. Indeed, low specificity decreasedFigure 5 Semi-automatic segmentation result of the breast
lesion based on the proposed method for the randomly
selected case (the colors were set to red for the lesion margin
and blue for the ROI margin). In order to facilitate the observation,
this image partially enlarged.the overall accuracy. Relative to the diagnostic performance
of the manual method, the sensitivity based on the semi-
automatic method was slightly decreased, but specificity
substantially increased, which resulted in better accuracy.
For analysis of the mean TIC derived from the proposed
method, the accuracy was greatest when using the quanti-
tative parameter SIslope, and the sensitivity was greatest
when using Einitial, while the specificity was greatest using
Epeak. For analysis of the lesion region extracted by the
semi-automatic method, again the greatest accuracy was
obtained when using SIslope, but the specificity was not
ideal (only 63.38%). The greatest specificity was obtained
when using MSI, and the greatest sensitivity obtained when
using Einitial. For mean MSI values derived from the man-
ual method, the accuracy only reached 63.35%. Thus it did
not result in a diagnostic performance that could be better
used in clinical practice.
The discrimination of benign and malignant lesions is
an important basis for breast conserving therapy. Based
on the results of the present study, we determined that
the quantitative parameter SIslope provided in the pro-
posed method could be used to increase the specificity
of breast DCE-MRI interpretation, and further improve
diagnostic performance. Among the quantitative param-
eters, SIslope was the best indicator for discrimination be-
tween IDCs and benign lesions. Traditionally, the optimal
threshold value was set at +10% [17,18,33]. However in
the present study, we found more accurate results if the
value was set at +9.7%. In our opinion, this previously se-
lected slope value might be only an empirical value, and
the establishment of a new optimal cutoff value could play
an important role in future interpretations of breast DCE-
MRIs, resulting in the avoidance of unnecessary surgeries
or biopsy for benign lesions. We anticipate the results of
the present study being most useful for guiding future
studies and for motivating other investigators to further
conduct retrospective analysis of similar datasets.
Over the last years, a number of studies on CAD for
differentiating benign from malignant breast tumors on
DCE-MRI have been carried out [16,38,42-47]. Yang
et al. developed a computer-aided detection scheme to
Figure 6 Quantitative parametric map obtained using the proposed method. A-G represent the mask image (before the injection of
contrast agent) covered by the lesion margin, MSI map, SIslope map, Einitial map, Epeak map, ESER map, and SEP map, respectively. Each image was
partially enlarged. The mean values were 1827.479 for MSI, 41.002 for SIslope, 292.210 for Einitial, 513.017 for Epeak, 74.002 for ESER, and 394.252 for
SEP. H is the mean curve of the TICs from the target region, which was quantitatively classified as type I. The above parameters for this curve
were 1043.546, 30.731, 284.749, 475.910, 73.884, and 385.402, respectively.
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sensitivity reached 91.3%, but the specificity was only
66% [16]. In the paper reported by Levman J [5], a semi-
automatic lesion segmentation based on a supervised
learning formulation was proposed for the distinction
between malignant and benign breast lesions, and im-
proved the AUC from 0.75 to 0.79 when compared with
traditional enhancement threshold method. Some previ-
ous papers also reported the value of hemodynamic pa-
rameters in the differentiating benign from malignant
breast lesions, and presented better diagnostic perform-
ance relative to conventional kinetic curve analysis
[10,47]. In a highly innovative paper [44], both morpho-
logical feature and kinetic curve were analyzed quantita-
tively, and a so-called morpho-dynamic index (MDI)
was proposed. Using the MDI cutoff value of 50%, the
sensitivity was 96.5% combined with specificity of 75.5%.
Compared with the above previous reports, the currently
proposed method provided more quantitative parame-
ters reflecting the enhancement information of breast le-
sions, and the maximum AUC (0.813) in combination
with sensitivity of 83.10% and specificity of 71.83% was
obtained based on SIslope derived from the mean curve.
In our opinion, the diagnostic accuracy might be higher
if the morphological features were also analyzed.
It must be emphasized that there are several limitations
regarding this study. First, the sample amount in this
study was insufficient to obtain a definitive conclusion. If
the case size was changed, both the optimal cutoff value
and accuracy rate might be changed accordingly. Second,
both the manual method and the semi-automatic method
were performed only once, hence the inter- and intra-observer variabilities were not investigated [26], although
we assumed that the semi-automatic method might offer
greater reproducibility by virtue of its simplicity and quan-
tification, especially when deployed across multiple sites
in a large-scale clinical trial [33,48]. Third, in this study,
we only analyzed the TICs from breast DCE-MRI, whereas
the morphologic features of the lesions were not utilized
for breast diagnosis, which could have further improved
the diagnostic accuracy of breast DCE-MRI [17,36].
Finally, in order to facilitate the segmentation, only
mass-like lesions were included in this study. If we
had included lesions with various characteristic pat-
terns, the results of the discrimination between IDCs
and benign lesions might have been different.
Conclusion
In conclusion, the semi-automatic method proposed in
this study can be applied to DCE-MRI for the distinction
between breast IDC and benign lesions. Compared with
the traditional method, the new method improved the
specificity and showed promise in the development of
future CAD of breast DCE-MRI.
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